Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Meri-Sisko Vuoristo"'
Autor:
Sonja Aho, Meri-Sisko Vuoristo, Jani Raitanen, Kirsi Mansikkamäki, Johanna Alanko, Henri Vähä-Ypyä, Riitta Luoto, Pirkko-Liisa Kellokumpu-Lehtinen, Tommi Vasankari
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Physical activity (PA) is known to be associated with lipid profiles and the risk of both cardiovascular diseases and cancer. The aim of this study was to evaluate the association of objectively measured PA, sedentary behaviour (S
Externí odkaz:
https://doaj.org/article/014456e774b24577be29ed26e51a5d9e
Autor:
Kalle E. Mattila, Siru Mäkelä, Soili Kytölä, Emma Andersson, Pia Vihinen, Susan Ramadan, Tanja Skyttä, Leena Tiainen, Meri-Sisko Vuoristo, Kristiina Tyynelä-Korhonen, Jussi Koivunen, Laura Kohtamäki, Kristiina Aittomäki, Micaela Hernberg
Publikováno v:
Acta oncologica (Stockholm, Sweden). 61(10)
Detectable circulating tumor DNA (ctDNA) has been associated with worse prognosis in melanoma patients.We studied plasma ctDNA as a prognostic biomarker in 19 patients with metastatic melanoma and a detectable tumor mutation (13 BRAF, 5 NRAS, and 1 K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dde8bc1d26f46c50784d8f501709f2db
https://pubmed.ncbi.nlm.nih.gov/36307938
https://pubmed.ncbi.nlm.nih.gov/36307938
Autor:
Leena Tiainen, Meri-Sisko Vuoristo, Kalle Mattila, Micaela Hernberg, Susan Ramadan, Kristiina Tyynelä-Korhonen, Siru Mäkelä, Laura Kohtamäki, Tanja Skyttä, Pia Vihinen, Jussi Koivunen
Publikováno v:
Acta Oncologica. 59:310-314
In the past decades, when dacarbazine-based chemotherapy was the treatment of choice, the median survival of patients with unresectable melanoma was only six to nine months and only 10–15% of the p...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c722566de3d854096947f8eec148d3f4
https://doi.org/10.1080/0284186x.2019.1670862
https://doi.org/10.1080/0284186x.2019.1670862
Autor:
Aho, Sonja, Meri-Sisko Vuoristo, Raitanen, Jani, Mansikkamäki, Kirsi, Alanko, Johanna, Vähä-Ypyä, Henri, Luoto, Riitta, Pirkko-Liisa Kellokumpu-Lehtinen, Vasankari, Tommi
Additional file 1. Questionnaire. Questionnaire form. The parts of the questionnaire concerning background and lifestyle factors were developed for this study. Our questionnaire included generally used Health Related Quality of Life Questionnaires (S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d044ef26a0af9c9ae4689a0422ed533
Autor:
Jani Raitanen, Meri Sisko Vuoristo, Pirkko-Liisa Kellokumpu-Lehtinen, Kirsi Mansikkamäki, Riitta Luoto, Sonja Aho, Johanna Alanko, Henri Vähä-Ypyä, Tommi Vasankari
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Public Health
BMC Public Health
Background Physical activity (PA) is known to be associated with lipid profiles and the risk of both cardiovascular diseases and cancer. The aim of this study was to evaluate the association of objectively measured PA, sedentary behaviour (SB), amoun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b16905a1a432c3d19c6f1ff1460d6bb4
https://doi.org/10.21203/rs.3.rs-34377/v1
https://doi.org/10.21203/rs.3.rs-34377/v1
Autor:
Gre P. M. Luyten, Roberto Delgado-Bolton, Piotr Rutkowski, João Paulo Paiva Prata, Marc Beishon, Maria Die Trill, Rémi Dendale, József Lövey, Orlando Catalano, Alberto Costa, Daniela Massi, Hannelore Kreckel, Meri Sisko Vuoristo, Gilly Spurrier-Bernard, A.M. Forsea, Olivier Michielin, Sapna Sheth, Andrea Ferrari, Simon Oberst, Esther Bastiaannet, Peter Mohr, Tiina Saarto, Michel W.J.M. Wouters, Philippe L. Pereira, Véronique Del Marmol, Peter Naredi
Publikováno v:
Critical reviews in oncology/hematology, vol. 122, pp. 164-178
Critical Reviews in Oncology/Hematology, 122, 164-178
Critical reviews in oncology/hematology, 122
Critical Reviews in Oncology/Hematology, 122, 164-178
Critical reviews in oncology/hematology, 122
Background: ECCO essential requirements for quality cancer care (ERQCC) are explanations and descriptions of challenges, organisation and actions that are necessary to give high-quality care to patients who have a specific type of cancer. They are wr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0f37631f8f8687590e6616d27d5db2e
https://serval.unil.ch/resource/serval:BIB_51AB46916AFB.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_51AB46916AFB.P001/REF.pdf
Autor:
Susan Ramadan, Pia Vihinen, Tanja Skyttä, Ilkka Koskivuo, Micaela Hernberg, Meri-Sisko Vuoristo, Pirkko-Liisa Kellokumpu-Lehtinen, Seppo Pyrhönen, Kari Syrjänen, Kristiina Tyynelä-Korhonen
Publikováno v:
Melanoma Research. 21:431-437
There are no identified biomarkers that could predict response to antiangiogenic or traditional chemoimmunotherapy in metastatic melanoma. We hypothesized that soluble angiogenic factor receptors might help us to identify patients responsive to treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::221dca366c7881d838ea56f046f5db0c
https://doi.org/10.1097/cmr.0b013e32834941d3
https://doi.org/10.1097/cmr.0b013e32834941d3
Autor:
Johanna Ivaska, Minna Kallioinen, Pia Vihinen, M. Hahka-Kemppinen, Meri-Sisko Vuoristo, Seppo Pyrhönen, Pirkko-Liisa Kellokumpu-Lehtinen, Kari Syrjänen
Publikováno v:
Vihinen, P, Kallioinen, M, Vuoristo, M-S, Ivaska, J, Syrjänen, K J, Hahka-Kemppinen, M, Kellokumpu-Lehtinen, P-L & Pyrhönen, S O 2007, ' Serum angiogenin levels predict treatment response in patients with stage IV melanoma ', Clinical and Experimental Metastasis, vol. 24, no. 7, pp. 567-574 . https://doi.org/10.1007/s10585-007-9093-7
This work was conducted to find out new potential serum markers and study their role as predictive factors in patients with metastatic melanoma. Serum samples from 68 patients with stage IV malignant melanoma were collected just before current treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d08b8be879f2abcff11915160b3d7083
https://doi.org/10.1007/s10585-007-9093-7
https://doi.org/10.1007/s10585-007-9093-7
Autor:
Meri-Sisko Vuoristo
Publikováno v:
Cancer Genetics and Cytogenetics. 176:54-57
The interleukin-10 gene (IL-10) is polymorphic. The genotypes result in inter-individual differences in IL-10 production, which may play a role in the pathophysiology and the clinical course of melanoma and other cancers. We analyzed the frequency of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98616616be9670df1f382845ab042f2c
https://doi.org/10.1016/j.cancergencyto.2007.03.002
https://doi.org/10.1016/j.cancergencyto.2007.03.002
Autor:
Seppo Pyrhönen, Meri-Sisko Vuoristo, Merja Korpela, Leena-Maija Parvinen, M Hahka-Kemppinen, Pirkko Kellokumpu-Lehtinen, Hanna Seppä
Publikováno v:
Melanoma Research. 15:291-296
This randomized phase II study was designed to compare the efficacy and tolerability of dacarbazine (DTIC) and bleomycin, vincristine, lomustine and DTIC (BOLD) combined with natural interferon-alpha (nIFN-alpha) or recombinant interferon-alpha2b (rI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4148a172910ccb977e0229976fb57330
https://doi.org/10.1097/00008390-200508000-00010
https://doi.org/10.1097/00008390-200508000-00010